Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveBrian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
Science Translational Medicine|November 16, 2022
Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergensElise G Liu, Biyan Zhang, Victoria Martin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH InvestigatorsSayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
JAMA|February 23, 2019
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical TrialDavid M Fleischer, Matthew Greenhawt, Gordon Sussman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2025
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
Pageof 8